Company
Kite Pharma
We are singularly focused on achieving cures with cell therapy.
Also known as Kite, Kite Pharma, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Kite Pharma, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
At Kite, we are singularly focused on achieving cures with cell therapy. Our goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.
Funding snapshot
- Total raised
- $79.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $50M2014-04-25
Funding rounds
- Round, 2014
- $50M2014-04-25, SEC form D sold, 15 investors
- Round, 2013
- $16.4M2013-05-10, SEC form D sold, 31 investors
- Round, 2012
- $250K2012-11-30, SEC form D sold, 1 investor
- Round, 2011
- $12.5M2011-02-25, SEC form D sold, 40 investors
Products
- Other
- Yescarta
Loading relationship preview